Figure. Mean (SE) Percentage Change in Calculated Low-Density Lipoprotein Cholesterol Level From Baseline Over Time by Double-Blind (DB) Treatment Group.
The receiving-treatment period ends at the last infusion date plus 35 days. IV indicates intravenous; Q4W, every 4 weeks.